DrugPatentWatch Database Preview

Details for Patent: 6,899,699

« Back to Dashboard

Which drugs does patent 6,899,699 protect, and when does it expire?

Patent 6,899,699 protects NORDITROPIN FLEXPRO, LEVEMIR FLEXTOUCH, NOVOLOG FLEXTOUCH, FIASP FLEXTOUCH, OZEMPIC, RYZODEG 70/30, SAXENDA, TRESIBA, and XULTOPHY 100/3.6, and is included in nine NDAs.

This patent has eleven patent family members in nine countries.

Summary for Patent: 6,899,699

Title:	Automatic injection device with reset feature
Abstract:	The present invention relates to a dose setting and expelling device comprising a drive member and a dose setting mechanism which simultaneously sets a given dose and stores the energy necessary for a subsequently driving the drive member in order to expel a dose of medicine from an injection device. According to the invention the dose setting mechanism allows adjustment in both directions, such that a given set dose can be reduced or cancelled by reversing the input motion, typically by rotating a setting member backwardly, this in contrast to the known devices which either requires an additional release mechanism or which cannot be reversed at all.
Inventor(s):	Enggaard; Christian (Hiller.o slashed.d, DK)
Assignee:	Novo Nordisk A/S (Bagsvaerd, DK)
Application Number:	10/038,781
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 6,899,699
Patent Claim Types: see list of patent claims	Device; Use;

Drugs Protected by US Patent 6,899,699

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Novo Nordisk Inc	NORDITROPIN FLEXPRO	somatropin recombinant	INJECTABLE;INJECTION	021148-008	Mar 1, 2010	BX	RX	No	No			Y
Novo Nordisk Inc	NORDITROPIN FLEXPRO	somatropin recombinant	INJECTABLE;INJECTION	021148-009	Mar 1, 2010	BX	RX	No	No			Y
Novo Nordisk Inc	NORDITROPIN FLEXPRO	somatropin recombinant	INJECTABLE;INJECTION	021148-010	Mar 1, 2010		RX	No	No			Y
Novo Nordisk Inc	NORDITROPIN FLEXPRO	somatropin recombinant	INJECTABLE;INJECTION	021148-011	Jan 23, 2015		RX	No	No			Y

Foreign Priority and PCT Information for Patent: 6,899,699

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Denmark	2001 00018	Jan 05, 2001

Non-Orange Book US Patents Family Members for Patent 6,899,699

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
8,672,898	Automatic injection device with reset feature
9,486,588	Automatic injection device with reset feature

International Family Members for US Patent 6,899,699

Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	296650
China	1313168
China	1509193
Germany	60204422